APPLICATION
ANDA077022
TYPE
ANDA
ORIGINAL APPROVAL
2004-11-23
LATEST ACTION
2020-11-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
CILOSTAZOLPrescription
CILOSTAZOL 100MG · TABLET · ORAL
CILOSTAZOLPrescription
CILOSTAZOL 50MG · TABLET · ORAL
Approval history
2020-11-18Labeling · Supplement 9 · standardAP
2017-03-21Labeling · Supplement 8 · standardAP
2010-07-06Labeling · Supplement 7AP
2010-05-27Labeling · Supplement 5AP
2008-02-14Labeling · Supplement 3AP
2006-02-14Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.